Compile Data Set for Download or QSAR
maximum 50k data
Found 178 with Last Name = 'iwakiri' and Initial = 'k'
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159725(US9035059, 19-4)
Affinity DataIC50:  2nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)
Affinity DataIC50:  4nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159724(US9035059, 19-3)
Affinity DataIC50:  4nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159732(US9035059, 20-4)
Affinity DataIC50:  5nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159705(US9035059, 18-7)
Affinity DataIC50:  7nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159711(US9035059, 18-16)
Affinity DataIC50:  10nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159740(US9035059, 24-11 | US9035059, 24-5/24-6)
Affinity DataIC50:  10nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159736(US9035059, 23-3)
Affinity DataIC50:  13nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)
Affinity DataIC50:  13nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159730(US9035059, 20-2)
Affinity DataIC50:  14nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159735(US9035059, 23-2)
Affinity DataIC50:  14nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159657(US9035059, 7-76)
Affinity DataIC50:  16nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159729(US9035059, 19-12)
Affinity DataIC50:  23nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159701(US9035059, 17-5)
Affinity DataIC50:  24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159636(US9035059, 6-75)
Affinity DataIC50:  24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159682(US9035059, 10-5/10-6)
Affinity DataIC50:  25nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159681(US9035059, 10-3/10-4)
Affinity DataIC50:  26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159708(US9035059, 18-12)
Affinity DataIC50:  26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159624(US9035059, 6-33)
Affinity DataIC50:  26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159727(US9035059, 19-8)
Affinity DataIC50:  28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159615(US9035059, 6-17)
Affinity DataIC50:  28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159707(US9035059, 18-11)
Affinity DataIC50:  29nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159666(US9035059, 8-5)
Affinity DataIC50:  29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159734(US9035059, 23-1 | US9035059, 24-1/24-2)
Affinity DataIC50:  29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159723(US9035059, 19-2)
Affinity DataIC50:  30nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159622(US9035059, 6-31)
Affinity DataIC50:  31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159623(US9035059, 6-32)
Affinity DataIC50:  31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159683(US9035059, 10-7/10-8)
Affinity DataIC50:  31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159718(US9035059, 18-25)
Affinity DataIC50:  33nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159741(US9035059, 24-7/24-8)
Affinity DataIC50:  34nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159616(US9035059, 6-18)
Affinity DataIC50:  35nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159667(US9035059, 8-6)
Affinity DataIC50:  35nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159625(US9035059, 6-34)
Affinity DataIC50:  36nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159702(US9035059, 17-6)
Affinity DataIC50:  39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159681(US9035059, 10-3/10-4)
Affinity DataIC50:  39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159633(US9035059, 6-64)
Affinity DataIC50:  40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159699(US9035059, 17-1)
Affinity DataIC50:  40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159739(US9035059, 24-3/24-4)
Affinity DataIC50:  42nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159685(US9035059, 10-11 | US9035059, 10-12)
Affinity DataIC50:  42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159646(US9035059, 7-32)
Affinity DataIC50:  42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159704(US9035059, 18-6)
Affinity DataIC50:  43nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159687(US9035059, 10-15/10-16)
Affinity DataIC50:  44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159682(US9035059, 10-5/10-6)
Affinity DataIC50:  44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159659(US9035059, 7-81)
Affinity DataIC50:  45nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159700(US9035059, 17-2)
Affinity DataIC50:  45nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159680(US9035059, 9-24)
Affinity DataIC50:  46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159679(US9035059, 9-23)
Affinity DataIC50:  46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159630(US9035059, 6-48)
Affinity DataIC50:  49nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159634(US9035059, 6-65)
Affinity DataIC50:  51nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM159651(US9035059, 7-56)
Affinity DataIC50:  52nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 178 total ) | Next | Last >>
Jump to: